Variant report
Variant | nsv519235 |
---|---|
Chromosome Location | chr5:114404806-114407661 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:114234220..114234829-chr5:114405733..114406270,2 | MCF-7 | breast: | |
2 | chr5:113785791..113786752-chr5:114405185..114405973,2 | MCF-7 | breast: | |
3 | chr5:114139185..114139978-chr5:114404825..114405439,2 | MCF-7 | breast: | |
4 | chr5:113014328..113015260-chr5:114404740..114405272,3 | K562 | blood: | |
5 | chr5:114404877..114405516-chr5:114433463..114434454,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4705516 | chr5:114404806-114404807 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs567392381 | chr5:114404823-114404824 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557637982 | chr5:114404829-114404830 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148036860 | chr5:114404833-114404834 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140480910 | chr5:114404840-114404841 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541345656 | chr5:114404844-114404845 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550040368 | chr5:114404868-114404869 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191979608 | chr5:114404880-114404881 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374495316 | chr5:114404928-114404929 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75138021 | chr5:114404937-114404938 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564828934 | chr5:114404973-114404974 | Enhancers Active TSS ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533477548 | chr5:114405012-114405013 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150435107 | chr5:114405028-114405029 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553196295 | chr5:114405044-114405045 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543959401 | chr5:114405070-114405071 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545226676 | chr5:114405076-114405077 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561055668 | chr5:114405130-114405131 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117892620 | chr5:114405131-114405132 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10057474 | chr5:114405133-114405134 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs386691367 | chr5:114405174-114405175 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563619180 | chr5:114405217-114405218 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532366382 | chr5:114405287-114405288 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs117194226 | chr5:114405320-114405321 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565764397 | chr5:114405355-114405356 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185361942 | chr5:114405430-114405431 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190238320 | chr5:114405431-114405432 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182518700 | chr5:114405451-114405452 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs73780021 | chr5:114405472-114405473 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs185862230 | chr5:114405502-114405503 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571109903 | chr5:114405543-114405544 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138349610 | chr5:114405566-114405567 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558585956 | chr5:114405582-114405583 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572113194 | chr5:114405592-114405593 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112804007 | chr5:114405594-114405595 | Enhancers Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554706658 | chr5:114405618-114405619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574516852 | chr5:114405628-114405629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149944893 | chr5:114405646-114405647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370326396 | chr5:114405655-114405656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35575013 | chr5:114405657-114405658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs56413505 | chr5:114405687-114405688 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs563431971 | chr5:114405691-114405692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs532414200 | chr5:114405709-114405710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs60764006 | chr5:114405715-114405716 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs55695948 | chr5:114405718-114405719 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs188332186 | chr5:114405730-114405731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542230902 | chr5:114405762-114405763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548249492 | chr5:114405781-114405782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11951180 | chr5:114405806-114405807 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs139013104 | chr5:114405807-114405808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149431441 | chr5:114405870-114405871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:114404000-114405600 | ZNF genes & repeats | GM12878-XiMat | blood |
2 | chr5:114404200-114405000 | Active TSS | Dnd41 | blood |
3 | chr5:114404400-114405000 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr5:114404600-114405000 | Enhancers | Liver | Liver |
5 | chr5:114404600-114405400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr5:114404600-114405600 | Enhancers | A549 | lung |
7 | chr5:114404800-114405000 | Enhancers | HepG2 | liver |
8 | chr5:114405200-114405400 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr5:114405200-114405600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr5:114405200-114405600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr5:114405200-114405600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr5:114405400-114405600 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr5:114405400-114405800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr5:114405400-114406600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
15 | chr5:114405600-114407600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
16 | chr5:114405600-114408200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
17 | chr5:114405600-114408200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
18 | chr5:114405800-114408000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
19 | chr5:114406600-114406800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
20 | chr5:114406600-114408200 | Weak transcription | Fetal Brain Male | brain |
21 | chr5:114407400-114409000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
22 | chr5:114407600-114408800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
23 | chr5:114407600-114409200 | Enhancers | HUES6 Cell Line | embryonic stem cell |